2010, Number 4
PDF size: 149.50 Kb.
Text ExtractionNo abstract
Pitt SC, Sippel RS, Chen H. Contralateral papillary thyroid cancer: does size matter? Am J Surg 2009;197: 342-7.
Ito Y, Higashiyama T, Takamura Y, et al. Prognosis of patients with benign thyroid diseases accompanied by incidental papillary carcinoma undetectable on preoperative imaging tests. World J Surg 2007; 31: 1672-6.
Sakorafas GH, Stafyla V, Kolettis T, et al. Microscopic papillary thyroid cancer as an incidental finding in patients treated surgically for presumably benign thyroid disease. J Postgrad Med 2007; 53: 23-6.
Torlontano M, Attard M, Crocetti U, et al. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 2004; 89: 3402-7.
Sonkar AA, Rajamanickam S, Singh D. Papillary thyroid carcinoma: debate at rest. Indian J Cancer 2010; 47: 206-16.
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-214.
Pacini F, Schlumberger M, Dralle H, et al. European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154: 787-803.
Pitoia F, Ward L, Wohllk N, et al. Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer. Arq Bras Endocrinol Metabol 2009; 53: 884-7.
Sherman SI, Angelos P, Ball DW, et al. National ComprehensiveCancer Network Thyroid Carcinoma Panel. Thyroid carcinoma. J Natl Compr Canc Netw 2007; 5: 568-621.
LiVolsi VA. Papillary carcinoma tall cell variant (TCV): a review. Endocr Pathol 2010; 21: 12-5.
Sheu SY, Grabellus F, Schwertheim S, et al. Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer 2010; 102: 376-82.
Pita JM, Banito A, Cavaco BM, et al. Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas. Br J Cancer 2009; 101: 1782-91.
Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007; 246: 375-81.
Lin JD. Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer. Med Oncol 2010; 27: 510-8.
Toniato A, Boschin I, Casara D, et al. Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol 2008; 15: 1518-22.
Verburg FA, Mäder U, Luster M, et al. Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases. Eur J Endocrinol 2009; 160: 619-24.
Mazzaferri EL. What is the optimal initial treatment of low-risk papillary thyroid cancer (and why is it controversial)? Oncology (Williston Park) 2009; 23: 579-88.
Arora N, Turbendian HK, Kato MA, et al. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 2009; 19: 473-7.
Rivera M, Ricarte-Filho J, Tuttle RM, Ganly I, Shaha A, Knauf J, et al. Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension. Thyroid 2010; 20: 1085-93.
Hurtado-Lopez LM. La extension del cáncer bien diferenciado de tiroides y su relación con la morbilidad quirúrgica. Cir Cir 2007; 75: 71-74.